Advertisement
Advertisement
LNSR
LENSAR, Inc. Common Stock
6.04
USDSponsored
+0.30
+5.32%
Aug 07, 15:59 UTC -4
Closed
After-Market
6.05
+0.01
+0.17%
LNSR Earnings Reports
Positive Surprise Ratio
LNSR beat 9 of 22 last estimates.
41%
Next Report
In 4 Days
Date of Next Report
Aug 13, 2026
Estimate for Q2 26 (Revenue/ EPS)
$14.94M
/-$0.16
Implied change from Q1 26 (Revenue/ EPS)
+11.28%
/--
Implied change from Q2 25 (Revenue/ EPS)
+7.23%
/+6.67%
LENSAR, Inc. Common Stock earnings per share and revenue
On May 08, 2026, LNSR reported earnings of 0.00 USD per share (EPS) for Q1 26, missing the estimate of 0.18 USD, resulting in a -100.00% surprise. Revenue reached 13.43 million, compared to an expected 13.72 million, with a -2.12% difference. The market reacted with a +7.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.16 USD, with revenue projected to reach 14.94 million USD, implying an -- of --% EPS, and increase of 11.28% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
FAQ
What were LENSAR, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, LENSAR, Inc. Common Stock reported EPS of $0.00, missing estimates by -100%, and revenue of $13.43M, -2.12% below expectations.
How did the market react to LENSAR, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 7.84%, changed from $5.23 before the earnings release to $5.64 the day after.
When is LENSAR, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 13, 2026.
What are the forecasts for LENSAR, Inc. Common Stock's next earnings report?
Based on 3
analysts, LENSAR, Inc. Common Stock is expected to report EPS of -$0.16 and revenue of $14.94M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement